Next Article in Journal
Quantitative Trait Locus Mapping of Marsh Spot Disease Resistance in Cranberry Common Bean (Phaseolus vulgaris L.)
Previous Article in Journal
Wheat Elongator Subunit 4 Negatively Regulates Freezing Tolerance by Regulating Ethylene Accumulation
Previous Article in Special Issue
Isolation of Decidual Macrophages and Hofbauer Cells from Term Placenta—Comparison of the Expression of CD163 and CD80
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 14
10.3390/ijms23147637
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Uterine Deletion of Bmal1 Impairs Placental Vascularization and Induces Intrauterine Fetal Death in Mice

by
Masanori Ono
1,2,†,
Natsumi Toyoda
1,3,†,
Kyosuke Kagami
1,
Takashi Hosono
1,4,
Takeo Matsumoto
1,
Shin-ichi Horike
5,
Rena Yamazaki
1,
Mitsuhiro Nakamura
1,6,
Yasunari Mizumoto
1,
Tomoko Fujiwara
7,
Hitoshi Ando
4,
Hiroshi Fujiwara
1,* and
Takiko Daikoku
3,*
1
Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kanazawa University, Takaramachi 13-1, Kanazawa 920-8641, Japan
2
Department of Obstetrics and Gynecology, Tokyo Medical University, Shinjuku, Tokyo 160-0023, Japan
3
Division of Animal Disease Model, Research Center for Experimental Modeling of Human Disease, Kanazawa University, Takaramachi 13-1, Kanazawa 920-8641, Japan
4
Department of Cellular and Molecular Function Analysis, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8640, Japan
5
Division of Integrated Omics Research, Research Center for Experimental Modeling of Human Disease, Kanazawa University, Kanazawa 920-8640, Japan
6
Department of Obstetrics and Gynecology, Public Central Hospital of Matto Ishikawa, Hakusan 924-8588, Japan
7
Department of Human Life Environments, Kyoto Notre Dame University, Kyoto 606-0847, Japan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2022, 23(14), 7637; https://doi.org/10.3390/ijms23147637
Submission received: 27 June 2022 / Revised: 8 July 2022 / Accepted: 9 July 2022 / Published: 11 July 2022
(This article belongs to the Special Issue Reproductive Immunology and Pregnancy 2.0)
Browse Figures
Review Reports Versions Notes

Abstract

:
Recently, it was demonstrated that the expression of BMAL1 was decreased in the endometrium of women suffering from recurrent spontaneous abortion. To investigate the pathological roles of uterine clock genes during pregnancy, we produced conditional deletion of uterine Bmal1 (cKO) mice and found that cKO mice could receive embryo implantation but not sustain pregnancy. Gene ontology analysis of microarray suggested that uterine NK (uNK) cell function was suppressed in cKO mice. Histological examination revealed the poor formation of maternal vascular spaces in the placenta. In contrast to WT mice, uNK cells in the spongiotrophoblast layer, where maternal uNK cells are directly in contact with fetal trophoblast, hardly expressed an immunosuppressive NK marker, CD161, in cKO mice. By progesterone supplementation, pregnancy could be sustained until the end of pregnancy in some cKO mice. Although this treatment did not improve the structural abnormalities of the placenta, it recruited CD161-positive NK cells into the spongiotrophoblast layer in cKO mice. These findings indicate that the uterine clock system may be critical for pregnancy maintenance after embryo implantation.

1. Introduction

The uterus is a unique organ specialized for pregnancy, which achieves embryo implantation and fetal delivery. In women, dysmenorrhea is an important clinical sign to show functional or organic disorders of the uterus. Previously, we found that dysmenorrhea is associated with breakfast skipping [1]. Later, a similar positive relationship between breakfast skipping and dysmenorrhea has been shown elsewhere [2,3,4,5]. Recently, we further found that pregnant women who experienced dysmenorrhea at a younger age in the past had a higher incidence of developing hypertensive disorders of pregnancy (HDP) [6]. From these findings, we hypothesized that poor dietary habits during adolescence and young adulthood impair uterine functions and induce latent progression of obstetrics and gynecologic disorders (adolescent dietary habit-induced obstetric and gynecologic disease: ADHOGD) [7].
Since breakfast skipping enhanced starvation stress at the initial stage of the active phase, we proposed that breakfast skipping impairs reproductive functions by disturbing a circadian rhythm via central and/or peripheral clock systems [7,8]. Using a breakfast skipping murine model, we demonstrated that food intake directly regulates the circadian rhythm of the uterine clock [9]. We further found that abnormal starvation stress by irregular uptake of breakfast impaired uterine clock function in mice (in preparation). Consequently, we speculated that the uterine peripheral clock system is influenced by dietary habits and is involved in the mechanism of obstetric and gynecologic diseases.
The circadian oscillation is controlled by clock genes such as Period (Per1-3), Cryptochrome (Cry1-2), Circadian locomotor output cycles kaput (Clock), and Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1 (Bmal1). Systemic Bmal1 knockout (KO) female mice were reported to have disorders in multiple organs including multifactorial infertility [10]. However, although circadian expression of clock genes, such as Per1-3, Cry1-2, Bmal1, and Clock, was demonstrated in the murine and rat uterus [11,12], the precise roles of uterine clock genes in reproductive functions remain unclear. Recently, the expression of BMAL1 was demonstrated to be decreased in the endometrium of women suffering from recurrent spontaneous abortion. Researchers also showed that BMAL1-depleted decidual cells inhibited trophoblast invasion, suggesting that the endometrial clock plays an important role in human pregnancy [13].
Based on this background, to investigate the pathological roles of uterine clock genes during pregnancy, we created uterine Bmal1 cKO mice by crossing Bmal1-loxP [14] and progesterone receptor-cre mice [15,16]. In this study, we further examined the effects of uterine Bmal1-deletion on uterine functions, especially fertility.

2. Results

2.1. Uterine Bmal1 cKO Mice Gave No Live Birth

The present study focused on the roles of uterine clock genes in pregnancy events. Thus, we created Bmal1f/f/PRcre/+ (cKO) mice crossing with Bmal1-flox and PR-cre mice. The loss of BMAL1 in cKO female mice was confirmed by RT-PCR (Figure 1A), Western blotting (Figure 1B), and immunofluorescence (Figure 1C) using non-pregnant cKO and WT (Bmal1f/f/PR+/+) uteruses. To examine the effect of cKO on pregnancy outcome, we mated cKO and WT female mice with fertile C57BL/6 male mice. While seven out of eight WT vaginal plug-positive female mice produced pups, no cKO (n = 15) female mice produced live pups (Figure 1D).

2.2. cKO Female Mice Increased Incomplete Miscarriage after Day Six of Pregnancy

To determine the cause of no live birth in cKO female mice, we next examined stage-specific effects of cKO during pregnancy (day one of pregnancy = virginal plug). On day five of pregnancy, the embryo implantation sites in cKO showed no difference in numbers and morphological appearance as compared to WT (Table 1 and Figure 2A). On day six of pregnancy, the number of female mice with implantation and implantation sites was decreased in cKO compared to the WT (57.1% vs. 85.7%, 7.1 ± 0.67 vs. 9.4 ± 0.40, Table 1). The size of the decidual bed seemed smaller in cKO than in WT (Figure 2B).
Among cKO mice on day 8 of pregnancy (n = 30), 11 had no implantation sites, 7 showed resorption sites, and the remaining 12 had normal implantation sites (Table 1 and Figure 2C). There were no differences in the numbers of embryo implantation sites among implantation-positive mice between the cKO and WT. At this stage of pregnancy, branches of the maternal uterine vessels in the mesometrial region become dilated to support fetoplacental development in WT (Figure 2D, green-dotted ellipse); however, vessel dilatation in this region seemed poor in the cKO mice (Figure 2D, red-dotted ellipse). The calculated pixel areas of the blood vessel cavities in the mesometrial region in the cKO seem decreased compared to those in WT, although the difference is not significant (Figure 2E).

2.3. cKO Mice Showed Abnormal Placental Formation on Day Twelve of Pregnancy

On day 12 of pregnancy, normal implantation sites were observed in 17 out of 20 (85.0%) WT mice and in 8 (20.5%) out of 39 cKO mice (Table 1 and Figure 3A). Among implantation-positive mice, the numbers of implantation sites in cKO mice were lower than those in WT mice (7.6 ± 1.00 in the cKO group and 9.5 ± 0.46 in the control group, respectively). At this stage of pregnancy, the placenta has three layers: an outer layer of trophoblast giant cells, a middle spongiotrophoblast layer (junctional zone), and the inner labyrinth layer [17]. Maternal vessels contained denucleated red blood cells, whereas fetal vessels still had nucleated erythrocytes. Therefore, we could clearly distinguish maternal vessels from fetal vessels in the placenta using HE staining and found that the placenta of cKO mice had abnormalities in vascular structures. The labyrinth formation was impaired and the areas of maternal vessels became narrowed (Figure 3B). The ratio of calculated areas of maternal vessels (green-dotted areas) among the total areas of both maternal and fetal (red-dotted areas) vessels in cKO mice (Figure 3C) was significantly decreased than those in WT mice (Figure 3D).

2.4. cKO Mice Showed Functional Changes in the Uterine Immune Environment

To investigate the key genes related to uterine functional changes in cKO mice, we performed microarray analysis using uterine tissues of WT and cKO mice. In a total of 20,983 genes, up-regulated genes were defined as those with both up-regulated in ZT0 and ZT12 (fold-change > 1; 6147 genes) and were selected by multiplying the absolute value of each WAD (>0.02; 597 genes), whereas down-regulated genes were those with both down-regulated (fold-change < 1; 5169 genes) and were selected (>0.02; 515 genes) as described previously [18]. Gene ontology biological process term enrichment analyses of the identified up- and down-regulated genes detected by WAD were performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) with the threshold at a p-value < 0.05, and the top 11 groups are presented [18] (Figure 4A). Since the gene ontology terms of immune responses including NK cell activation were dominantly detected in the down-regulated group, we focused on the uterine NK (uNK) cells.
uNK cells are recruited and activated by ovarian hormones, which are dominant immune cells at the maternal-fetal boundary in pregnancy [19]. uNK cells release cytokines or chemokines that induce trophoblast invasion, tissue remodeling, embryonic development, and placentation [20]. We first analyzed the localization of uNK cells using Dolichos biflorus agglutinin (DBA) and periodic Schiff (PAS) staining methods [21,22]. Murine uNK cells are classified into two subsets by DBA and PAS reactivity [23]. DBA-positive (PAS+DBA+) uNK cells produce angiogenic factors [24] and progesterone-induced blocking factor [25], and IFN-γ-producing uNK cells contribute to vessel instability and facilitate pregnancy-induced remodeling of decidual arteries [26,27]. It was reported that DBA-negative (PAS+/DBA-) NK cells exist in the spongiotrophoblast layer, which did not contain DBA-positive uNK cells [25].
On day twelve of pregnancy, abundant DBA-positive uNK cells (Figure 4B, white arrowheads) were detected in the decidua of the WT pregnant mice, whereas DBA-negative (PAS+/DBA-) NK cells (Figure 4B, black arrowheads) were observed in the spongiotrophoblast layer as reported previously [25]. In cKO mice, numbers of DBA-positive and -negative uNK cells were significantly lower than those in WT (Figure 4C). Next, we examined the expression of CD161, a differentiation marker of NK cells, on uNK cells [28]. Recently, CD161 was reported as one of the immune checkpoint molecules on NK cells [29] and its involvement in cancer-associated immunosuppression was proposed [30]. In the WT placenta, CD161 was expressed on uNK cells in both the decidua (upper panel of Figure 4D, white arrowheads) and spongiotrophoblast layers (upper panel of Figure 4D, arrows). In contrast, uNK cells in the decidua layer of cKO mice expressed CD161 (lower panel of Figure 4D, white arrowheads), but its expression was hardly detected in uNK cells in the spongiotrophoblast layer (lower panel of Figure 4D, arrows).

2.5. Progesterone Supplementation Rescues Perinatal Outcomes in cKO Female Mice

Since systemic Bmal1 knockout (KO) mice have infertility accompanied by decreased progesterone (P4) levels due to decreased ovarian function, serum P4 levels in cKO mice were measured. As shown in Figure 5A, on day eight of pregnancy, the P4 level in WT was 65.34 ± 8.04 ng/µL (n = 5). The P4 level in cKO with normal implantation was comparable to WT (48.44 ± 16.96 ng/µL; n = 2); however, that of cKO with resorption was significantly lower (4.75 ± 2.66 ng/µL; n = 4) than WT. On day twelve of pregnancy, the P4 level in WT was 58.06 ± 8.08 ng/μL (n = 4). The P4 level in cKO with live implantation was higher than in WT (88.85 ± 38.29 ng/µL; n = 4); however, the P4 level of the mice without implantation was significantly lower than WT (22.68 ± 20.09 ng/µL; n = 6). Thus, we next examine whether P4 supplementation rescues pregnancy in cKO female mice.
cKO mice with P4 supplementation (n = 5) increased serum P4 levels by more than 145 ng/μL, which was significantly higher than those in WT (Figure 5A). In this condition, the ratio of the mice with normal implantation sites was increased in cKO supplemented with P4 compared to non-treated cKO on both days 8 and 12 of pregnancy (80.0% vs. 40.0% and 57.9% vs. 20.5%, respectively) (Table 1 and Table 2). Notably, in some P4-treated cKO mice (8 out of 12, 66.7%), live pups could be obtained by cesarean section on pregnancy day twenty. In some P4-treated cKO mice, although the implanting embryo showed a normal appearance on day eight of pregnancy, the decidualization of embryo-surrounding decidua was incomplete (Figure 5D).
On day twelve of pregnancy, a severe structural abnormality was observed in the labyrinth layer of P4-treated cKO, which had not been observed in non-treated cKO mice. Although the structure of the labyrinth seems fragile, the areas of maternal and fetal vessels were dilated enough in P4-treated cKO (Figure 5E). The fetuses bearing these malformed placentae would probably have miscarried much earlier if not for P4 supplementation. There were no differences in the ratio of calculated areas of maternal vessels among the total areas of both maternal and fetal vessels between P4-treated cKO and WT mice (Figure 5F).
In the placenta of P4-treated cKO mice, abundant DBA-positive uNK cells (Figure 5G, white arrowheads) were detected in the decidua as observed in those of WT mice. Although DBA-negative (PAS+/DBA-) NK cells (Figure 5G, black arrowheads) were observed in the spongiotrophoblast layer, the numbers were not recovered as compared with non-treated cKO mice (Figure 5H). However, in contrast to non-treated cKO mice, CD161-positive uNK cells were detected in the spongiotrophoblast layer (Figure 5I, arrows).

3. Discussion

This study demonstrated that mice lacking BMAL1 expression in the uterus can implant embryos but not sustain a pregnancy. The previous studies showed the possible involvement of Bmal1 in regulation of male and female reproductive functions [31,32,33]. It was shown that systemic Bmal1 KO female mice can ovulate but both embryo development and ovarian production of progesterone (P4) are not enough to achieve embryo implantation [10,34]. Later, steroidogenic factor-1 (SF-1) expression-dependent Bmal1-deleted female mice (Bmal1SF1d/d) were demonstrated to fail embryo implantation, which could be rescued by P4 supplementation or normal ovarian transplantation [35], indicating that poor ovarian production of P4 is one of the main causes for infertility of Bmal1 KO female mice. However, the precise roles of uterine clock genes in pregnancy have been unclear. In this regard, the present study is the first report to show that the uterine clock system is critical for a successful pregnancy.
Histological examinations revealed that cKO mice developed abnormal placental structures. The main feature of placental abnormality in cKO mice was the poor formation of maternal vascular space. Since maternal vascular spaces become narrowed in cKO mice, maternal blood flow into the intervillous spaces in the labyrinth layer is considered to be reduced, suggesting the impaired maternal-fetal nutritional exchanges through this layer. During human placental formation, extravillous trophoblast (EVT) invades the maternal decidua and reconstructs maternal spiral arteries, which is a process essential to maintaining adequate maternal blood flow into the intervillous spaces, by reducing arterial contractility [36]. If this vascular reconstruction is interrupted in the early stage of pregnancy, the subsequent poor blood supply to the intervillous space in the placenta will cause placental dysfunction and induce various pregnancy complications, such as hypertensive disorders of pregnancy (HDP), fetal growth restriction, preterm labor, abortions, and stillbirth in the late stage of pregnancy [37]. In terms of the impaired vascular reconstruction associated with abnormal placental formation, the pathogenesis of our cKO mouse model is corresponding to that of placental dysfunction in human pregnancy complications.
One of the most important properties of the uterus is the acceptance of hemi-allograft during pregnancy. Gene ontology analysis of microarray showed that the immune response genes were down-regulated in the cKO uterus, suggesting the involvement of immune dysfunction in the abnormal placental formation (Figure 3A). It was reported that the cellular immune responses and major cellular subsets, such as regulatory T cells, effector T cells, NK cells, monocytes, macrophages, and neutrophils are involved in the pathogenesis of HDP [38]. Among them, NK cells were shown to directly interact with EVT and regulate their invasion and vascular reconstruction [37]. In accordance with it, GO:0045954 “positive regulation of natural killer cell-mediated cytotoxicity” was detected as down-regulated genes by gene ontology analysis in cKO mice. In the human placenta, it was reported that uNK cells were decreased in placental bed biopsies from women with HDP compared to the control third-trimester decidua, suggesting that altered local cytokine balance may be important in defective trophoblast invasion and spiral artery transformation in these pathological pregnancies [39]. Therefore, we examined uNK distribution and their subtypes around the embryo implantation sites at early pregnancy and in the placenta at mid-pregnancy. In cKO mice, the numbers of NK cells expressing PAS(+)/DAB(-) in the spongiotrophoblast layer decreased and hardly expressed CD161. These findings indicate that the subtype of uNK cells in cKO mice is different from those in WT mice. This also suggests that functional changes in uNK cells were induced by clock gene deletion, especially in the spongiotrophoblast layer where maternal uNK cells directly interact with fetal trophoblast. Considering the immunosuppressive role of CD161 [29], this functional alteration of uNK cells may be critical for trophoblast function to sustain maternal-fetal immune tolerance.
Notably, although this treatment did not completely improve the structural abnormalities of the placenta, pregnancy could be sustained until the end of pregnancy in some cKO mice. It was reported that, although murine uNK cells do not express the classical progesterone receptor, progesterone affects the recruitment and function of uNK cells [25]. In accordance with it, this study showed that P4 supplementation could recruit CD161-positive NK cells into the spongiotrophoblast layer even in cKO mice. It was demonstrated that uNK cells express glucocorticoid receptors and progesterone can regulate NK cells via glucocorticoid receptor [40]. Allowing for a higher concentration of serum P4 in P4-supplemented cKO mice compared to WT mice, the possibility that expression of CD161 on uNK cells in the spongiotrophoblast layer was mediated through a glucocorticoid receptor pathway. As clinical evidence, progesterone supplement was demonstrated to prevent miscarriage in women with recurrent miscarriage of unclear etiology [41] and protect the onset of HDP [42]. Recently, it was also reported that progesterone supplement therapy is clinically effective for the functional failure of the placenta with structural abnormalities [43]. Our cKO model provides experimental evidence in support of this treatment for pregnancy complications.
This study has several limitations. First, we did not show the direct relationship between meal skipping and uterine clock dysfunction-induced miscarriage. Second, since clock genes may have non-clock functions, the deletion of uterine Bmal1 does not necessarily equal the dysfunction of the uterine clock system. In the future, it is necessary to validate this issue by experimentation using other clock-gene-deleted mice or by constitutively expressed BMAL1 in the uterus.
In conclusion, uterine deletion of Bmal1 impairs placental vascularization and induces intrauterine fetal death in mice. The maternal vascular spaces in the placenta were reduced in cKO mice, suggesting the presence of placental dysfunction. Since uNK cells in the spongiotrophoblast layer of the placenta did not express CD161, dysfunction in uNK cells is one of the possible mechanisms to induce failure of placental formation in cKO mice. Notably, P4 supplementation recruited CD161-positive NK cells into the spongiotrophoblast layer and rescued pregnant outcomes in some cKO mice. These findings indicate that the uterine clock system is critical for a successful pregnancy and suggest that P4 supplementation can partially recover clock-induced uterine dysfunction. This study also provides experimental evidence that the disorder of a uterine clock system can be a candidate to induce uterine dysfunction during pregnancy in ADHOGD.

4. Materials and Methods

4.1. Mice

We produced Bmal1f/f/PRcre/+ (cKO) mice by crossing Bmal-loxP mice (strain #007668, The Jackson Laboratory, Sacramento, CA, USA) [14] and PR-cre mice [44]. PR-cre mice were kindly provided by Dr. Francesco Demayo (the National Institutes of Health, Bethesda, MD, USA) and Dr. John P. Lydon (Baylor College of Medicine, Houston, TX, USA). C57BL/6-J male mice were purchased from Charles River (Yokohama, Japan) and used for experiments after checking fertility. All experimental procedures and housing conditions were approved by the Kanazawa University Animal Experiment Committee (AP-163729 and AP-214218). All animals were housed and cared for in accordance with the Institutional Guidelines for Experiments using Animals.

4.2. Analysis of Pregnancy Events

Female cKO and WT (Bmal1f/f/PR+/+) mice were mated with fertile C57BL/6-J male mice to induce pregnancy (Day 1 = virginal plug). To visualize the implantation sites on days 5 and 6 of pregnancy, 0.1 mL of 1% (w/v) Chicago Sky Blue 6B (Sigma, St. Louis, MO, USA) in saline was intravenously injected into mice [45]. To examine whether P4 supplementation maintains pregnancy, a Silastic implant (4 cm length × 0.31 cm diameter, Kaneka medical products, Osaka, Japan) containing P4 (Sigma-Aldrich, Saint Louis, MO, USA) was placed under dorsal skin on day 2 of pregnancy [45].

4.3. RT-PCR

RNA was extracted from the uteruses of WT and cKO mice with TRIzol Reagent (Thermo Fisher, Waltham, MA, USA) according to the manufacturer’s instructions. After removing contaminating genomic DNA with TURBO DNA-free Kit (Thermo Fisher, Waltham, MA, USA), one µg RNA was reverse-transcribed with Superscript II and oligo(dT) primer to prepare cDNA (Thermo Fisher, Waltham, MA, USA). PCR was performed as previously described [18,46]. The primer sequences for PCR are forward primer (5′-aaagaggcgtcgggacaaaa-3′) and reverse primer (5′-ccatctgctgccctgagaat-3′) for Bmal1, and forward primer (5′-ctctcgctttctggagggtg-3′) and reverse primer (5′-tcagtctccacagacaatgcc-3′) for Rplp0 as an internal control.

4.4. Western Blot Analysis

Tissue samples were prepared as previously described [47]. After measuring the protein concentration, extracts with SDS-PAGE sample buffer were boiled for 5 min. Samples were run on 10% SDS-PAGE gel and transferred to a polyvinylidene fluoride membrane. Membranes were blocked with 5% skim milk in Tris-buffered saline Tween 20 and probed with antibodies to BMAL1 (1:2000; Novus Biologicals, Centennial, CO, USA) or ACTIN (1:5000; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Blots were incubated with donkey anti-goat or donkey anti-rabbit IgG conjugated to peroxidase (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). All signals were detected using chemiluminescent reagents (GE Healthcare, Chicago, IL, USA). ACTIN was used as a loading control.

4.5. Immunofluorescence

Uteruses harvested from WT and cKO non-pregnant mice were fixed with 4% paraformaldehyde and embedded in OCT after being dehydrated with 30% sucrose. Frozen sections (10 µm) were stained with BMAL1 antibody (1:1000; Novus Biologicals, Centennial, CO, USA) and Hoechst.

4.6. Histology and Measurement of Blood Vessel Area

Formalin-fixed paraffin-embedded tissue sections (5 µm) were stained with hematoxylin and eosin for histological analysis. Blood vessel area in the decidua and the placenta were measured by Image—J software on days 8 and 12 of pregnancy, respectively [48].

4.7. Immunohistochemistry

Formalin-fixed paraffin-embedded tissue sections (5 µm) were subjected to immunohistochemistry with anti-CD161 rabbit polyclonal antibody (1:2000; Abcam ab197979, San Francisco, CA, USA) after antigen retrieval. The signal was visualized with DAB (Fujifilm Wako Pure Chemical Corporation, Osaka, Japan). Hematoxylin staining was used as counterstaining.

4.8. DBA Lectin and PAS Dual Staining

Formalin-fixed paraffin-embedded tissue sections (5 µm) were first stained with DBA lectin and then subjected to PAS staining. In brief, after antigen retrieval, sections were incubated with biotinylated DBA lectin (1:5000; Sigma) and visualized positive cells with DAB. Next, sections were incubated with 1% periodic acid (Fujifilm Wako Pure Chemical Corporation) for 20 min, with Schiff reagent (Fujifilm Wako Pure Chemical Corporation) for 30 min, and 0.5% sodium bisulfite solution (Fujifilm Wako Pure Chemical Corporation, Osaka, Japan) for 5 min. Hematoxylin was used for counter-staining.

4.9. Microarray Analysis

Uteruses were collected from matured WT and cKO mice at 9 am and 9 pm. RNA was extracted with an RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Cyanine-3 (Cy3)-labeled cRNA was prepared from 0.2 µg RNA using a Low Input Quick Amp Labeling Kit (Agilent) according to the manufacturer’s instructions. A total of 0.6 µg of Cy3-labelled cRNA was hybridized to SurePrint G3 Mouse GE microarray 8 × 60 K Ver. 2.0 (G4858A #74809, Agilent Technologies, Santa Clara, CA, USA) for 17 h at 65 °C in a rotating Agilent hybridization oven. After hybridization, microarrays were washed and slides were scanned immediately after washing on an Agilent DNA Microarray Scanner (G2539A) using the one color scan setting for 1 × 60 K array slides. The scanned images were analyzed with Feature Extraction Software 11.0.1.1 (Agilent) using default parameters to obtain background-subtracted and spatially detrended processed signal intensities. Data were normalized and filtered with three filters with GeneSpring software 12 (Agilent Technologies). Differentially expressed genes were extracted by the weighted average difference (WAD) ranking method [49].

4.10. P4 Assay

The concentration of P4 in mouse serum was measured by an enzyme-linked immunosorbent assay kit (Cayman, Ann Arbor, MI, USA). All samples were measured in triplicate.

5. Statistical Methods

Statistical analyses were performed by unpaired t-test (two-sided test). p values < 0.05 were accepted as statistically significant.

Author Contributions

Conceptualization, M.O., H.F. and T.D.; Methodology, T.D.; Validation, H.F. and T.D.; Formal analysis, N.T., S.-i.H., H.F. and T.D.; Investigation, M.O., N.T., K.K., T.H., T.M., S.-i.H. and T.D.; Resources, N.T. and T.D.; Data curation, S.-i.H.; Writing—original draft, M.O., H.F. and T.D.; Writing—review editing, M.O., R.Y., M.N., Y.M., T.F., H.A., H.F. and T.D.; Visualization, M.O., H.F. and T.D.; Supervision, H.A., H.F. and T.D.; Project administration, M.O.; Funding acquisition, M.O., T.F., H.F. and T.D. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported in part by Grants-in-Aid for Scientific Research [17H04337, 18K08470, 19H01617, 19K22681, 20K21651, and 21K18297], by a Japan Science and Technology Agency [19216689], and the Japan Agency for Medical Research and Development [19gk0110024h0002, 19gk0210016h0001, 19cm0106610h0002, and 20ck0106549h0001] from the Japanese government.

Institutional Review Board Statement

The animal study protocol was approved by the institutional Ethics Committee of Kanazawa University (AP-163729 (8 April 2016) and AP-214218 (26 March 2021)).

Acknowledgments

We thank Michihiro Mieda (Kanazawa University) and Jumpei Terakawa (Azabu University) for their technical support and valuable advice. We also thank Tae Mieda for her help with experiments.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ADHOGDadolescent dietary habit-induced obstetric and gynecologic disease
BMAL1brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1
CLOCKcircadian locomotor output cycles kaput
CRYcryptochrome
HRPhorse-radish peroxidase
OCToptimal cutting temperature
PERPeriod
uNKuterine natural killer
KOknockout
cKOconditional knockout
WTwild type

References

  1. Fujiwara, T. Skipping breakfast is associated with dysmenorrhea in young women in Japan. Int. J. Food Sci. Nutr. 2003, 54, 505–509. [Google Scholar] [CrossRef]
  2. Angelin, P.; Dileep, D.; Manju, T.; Veena, M.; Pradeep, D.; Amreen, K.; Soumitra, S. Effect of Skipping Breakfast on Young Girls’ Menstruation. Ind. J. Youth Adolesc. Health 2017, 4, 17–20. [Google Scholar]
  3. Abu Helwa, H.A.; Mitaeb, A.A.; Al-Hamshri, S.; Sweileh, W.M. Prevalence of dysmenorrhea and predictors of its pain intensity among Palestinian female university students. BMC Womens Health 2018, 18, 18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Hu, Z.; Tang, L.; Chen, L.; Kaminga, A.C.; Xu, H. Prevalence and Risk Factors Associated with Primary Dysmenorrhea among Chinese Female University Students: A Cross-sectional Study. J. Pediatr. Adolesc. Gynecol. 2020, 33, 15–22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Fujiwara, T.; Ono, M.; Iizuka, T.; Sekizuka-Kagami, N.; Maida, Y.; Adachi, Y.; Fujiwara, H.; Yoshikawa, H. Breakfast Skipping in Female College Students Is a Potential and Preventable Predictor of Gynecologic Disorders at Health Service Centers. Diagnostics 2020, 10, 476. [Google Scholar] [CrossRef]
  6. Nakayama, M.; Ono, M.; Iizuka, T.; Kagami, K.; Fujiwara, T.; Sekizuka-Kagami, N.; Maida, Y.; Obata, T.; Yamazaki, R.; Daikoku, T.; et al. Hypertensive disorders of pregnancy are associated with dysmenorrhea in early adulthood: A cohort study. J. Obstet. Gynaecol. Res. 2020, 46, 2292–2297. [Google Scholar] [CrossRef] [PubMed]
  7. Fujiwara, T.; Ono, M.; Mieda, M.; Yoshikawa, H.; Nakata, R.; Daikoku, T.; Sekizuka-Kagami, N.; Maida, Y.; Ando, H.; Fujiwara, H. Adolescent Dietary Habit-induced Obstetric and Gynecologic Disease (ADHOGD) as a New Hypothesis-Possible Involvement of Clock System. Nutrients 2020, 12, 1294. [Google Scholar] [CrossRef]
  8. Fujiwara, T.; Nakata, R. Skipping breakfast is associated with reproductive dysfunction in post-adolescent female college students. Appetite 2010, 55, 714–717. [Google Scholar] [CrossRef]
  9. Hosono, T.; Ono, M.; Daikoku, T.; Mieda, M.; Nomura, S.; Kagami, K.; Iizuka, T.; Nakata, R.; Fujiwara, T.; Fujiwara, H.; et al. Time-Restricted Feeding Regulates Circadian Rhythm of Murine Uterine Clock. Curr. Dev. Nutr. 2021, 5, nzab064. [Google Scholar] [CrossRef]
  10. Boden, M.J.; Varcoe, T.J.; Voultsios, A.; Kennaway, D.J. Reproductive biology of female Bmal1 null mice. Reproduction 2010, 139, 1077–1090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Johnson, M.H.; Lim, A.; Fernando, D.; Day, M.L. Circadian clockwork genes are expressed in the reproductive tract and conceptus of the early pregnant mouse. Reprod. Biomed. Online 2002, 4, 140–145. [Google Scholar] [CrossRef]
  12. Nakamura, T.J.; Moriya, T.; Inoue, S.; Shimazoe, T.; Watanabe, S.; Ebihara, S.; Shinohara, K. Estrogen differentially regulates expression of Per1 and Per2 genes between central and peripheral clocks and between reproductive and nonreproductive tissues in female rats. J. Neurosci. Res. 2005, 82, 622–630. [Google Scholar] [CrossRef]
  13. Lv, S.; Wang, N.; Ma, J.; Li, W.P.; Chen, Z.J.; Zhang, C. Impaired decidualization caused by downregulation of circadian clock gene BMAL1 contributes to human recurrent miscarriagedagger. Biol. Reprod. 2019, 101, 138–147. [Google Scholar] [CrossRef]
  14. Storch, K.F.; Paz, C.; Signorovitch, J.; Raviola, E.; Pawlyk, B.; Li, T.; Weitz, C.J. Intrinsic circadian clock of the mammalian retina: Importance for retinal processing of visual information. Cell 2007, 130, 730–741. [Google Scholar] [CrossRef] [Green Version]
  15. Daikoku, T.; Dey, S.K. Two faces of PTEN. Nat. Med. 2008, 14, 1192–1193. [Google Scholar] [CrossRef]
  16. Daikoku, T.; Hirota, Y.; Tranguch, S.; Joshi, A.R.; DeMayo, F.J.; Lydon, J.P.; Ellenson, L.H.; Dey, S.K. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008, 68, 5619–5627. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Cross, J.C.; Hemberger, M.; Lu, Y.; Nozaki, T.; Whiteley, K.; Masutani, M.; Adamson, S.L. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol. Cell Endocrinol. 2002, 187, 207–212. [Google Scholar] [CrossRef]
  18. Iizuka, T.; Wakae, K.; Ono, M.; Suzuki, T.; Mizumoto, Y.; Kitamura, K.; Horike, S.I.; Muramatsu, M.; Fujiwara, H. Activation-induced cytidine deaminase is a possible regulator of cross-talk between oocytes and granulosa cells through GDF-9 and SCF feedback system. Sci. Rep. 2021, 11, 3833. [Google Scholar] [CrossRef] [PubMed]
  19. Croy, B.A.; Kiso, Y. Granulated metrial gland cells: A natural killer cell subset of the pregnant murine uterus. Microsc. Res. Tech. 1993, 25, 189–200. [Google Scholar] [CrossRef] [PubMed]
  20. Zhang, X.; Wei, H. Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications. Front. Immunol. 2021, 12, 728291. [Google Scholar] [CrossRef] [PubMed]
  21. Paffaro, V.A., Jr.; Bizinotto, M.C.; Joazeiro, P.P.; Yamada, A.T. Subset classification of mouse uterine natural killer cells by DBA lectin reactivity. Placenta 2003, 24, 479–488. [Google Scholar] [CrossRef] [PubMed]
  22. Peng, J.; Monsivais, D.; You, R.; Zhong, H.; Pangas, S.A.; Matzuk, M.M. Uterine activin receptor-like kinase 5 is crucial for blastocyst implantation and placental development. Proc. Natl. Acad. Sci. USA 2015, 112, E5098–E5107. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Chen, Z.; Zhang, J.; Hatta, K.; Lima, P.D.; Yadi, H.; Colucci, F.; Yamada, A.T.; Croy, B.A. DBA-lectin reactivity defines mouse uterine natural killer cell subsets with biased gene expression. Biol. Reprod. 2012, 87, 81. [Google Scholar] [CrossRef]
  24. Lima, P.D.; Tu, M.M.; Rahim, M.M.; Peng, A.R.; Croy, B.A.; Makrigiannis, A.P. Ly49 receptors activate angiogenic mouse DBA(+) uterine natural killer cells. Cell Mol. Immunol. 2014, 11, 467–476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Bogdan, A.; Berta, G.; Szekeres-Bartho, J. PIBF positive uterine NK cells in the mouse decidua. J. Reprod. Immunol. 2017, 119, 38–43. [Google Scholar] [CrossRef] [PubMed]
  26. Ashkar, A.A.; Di Santo, J.P.; Croy, B.A. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 2000, 192, 259–270. [Google Scholar] [CrossRef] [Green Version]
  27. Zhang, J.H.; He, H.; Borzychowski, A.M.; Takeda, K.; Akira, S.; Croy, B.A. Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol. Reprod. 2003, 69, 404–411. [Google Scholar] [CrossRef]
  28. Kurioka, A.; Cosgrove, C.; Simoni, Y.; van Wilgenburg, B.; Geremia, A.; Bjorkander, S.; Sverremark-Ekstrom, E.; Thurnheer, C.; Gunthard, H.F.; Khanna, N.; et al. CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells. Front. Immunol. 2018, 9, 486. [Google Scholar] [CrossRef]
  29. Buckle, I.; Guillerey, C. Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer. Cancers 2021, 13, 4263. [Google Scholar] [CrossRef]
  30. Di, W.; Fan, W.; Wu, F.; Shi, Z.; Wang, Z.; Yu, M.; Zhai, Y.; Chang, Y.; Pan, C.; Li, G.; et al. Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples. Cancer Sci. 2021, 113, 756. [Google Scholar] [CrossRef]
  31. Schoeller, E.L.; Clark, D.D.; Dey, S.; Cao, N.V.; Semaan, S.J.; Chao, L.W.; Kauffman, A.S.; Stowers, L.; Mellon, P.L. Bmal1 Is Required for Normal Reproductive Behaviors in Male Mice. Endocrinology 2016, 157, 4914–4929. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Alvarez, J.D.; Hansen, A.; Ord, T.; Bebas, P.; Chappell, P.E.; Giebultowicz, J.M.; Williams, C.; Moss, S.; Sehgal, A. The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice. J. Biol. Rhythm. 2008, 23, 26–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Jiang, Y.; Li, S.; Xu, W.; Ying, J.; Qu, Y.; Jiang, X.; Zhang, A.; Yue, Y.; Zhou, R.; Ruan, T.; et al. Critical Roles of the Circadian Transcription Factor BMAL1 in Reproductive Endocrinology and Fertility. Front. Endocrinol. 2022, 13, 818272. [Google Scholar] [CrossRef] [PubMed]
  34. Ratajczak, C.K.; Boehle, K.L.; Muglia, L.J. Impaired steroidogenesis and implantation failure in Bmal1−/− mice. Endocrinology 2009, 150, 1879–1885. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Liu, Y.; Johnson, B.P.; Shen, A.L.; Wallisser, J.A.; Krentz, K.J.; Moran, S.M.; Sullivan, R.; Glover, E.; Parlow, A.F.; Drinkwater, N.R.; et al. Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice. Proc. Natl. Acad. Sci. USA 2014, 111, 14295–14300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Kaufmann, P.; Black, S.; Huppertz, B. Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 2003, 69, 1–7. [Google Scholar] [CrossRef] [Green Version]
  37. Pollheimer, J.; Vondra, S.; Baltayeva, J.; Beristain, A.G.; Knofler, M. Regulation of Placental Extravillous Trophoblasts by the Maternal Uterine Environment. Front. Immunol. 2018, 9, 2597. [Google Scholar] [CrossRef]
  38. Miller, D.; Motomura, K.; Galaz, J.; Gershater, M.; Lee, E.D.; Romero, R.; Gomez-Lopez, N. Cellular immune responses in the pathophysiology of preeclampsia. J. Leukoc. Biol. 2022, 111, 237–260. [Google Scholar] [CrossRef]
  39. Williams, P.J.; Bulmer, J.N.; Searle, R.F.; Innes, B.A.; Robson, S.C. Altered decidual leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: A comparison with late normal pregnancy. Reproduction 2009, 138, 177–184. [Google Scholar] [CrossRef] [Green Version]
  40. Guo, W.; Li, P.; Zhao, G.; Fan, H.; Hu, Y.; Hou, Y. Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells. Am. J. Reprod. Immunol. 2012, 67, 463–473. [Google Scholar] [CrossRef]
  41. Haas, D.M.; Hathaway, T.J.; Ramsey, P.S. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst. Rev. 2019, 2019, CD003511. [Google Scholar] [CrossRef]
  42. Wu, H.; Zhang, S.; Lin, X.; He, J.; Wang, S.; Zhou, P. Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: A systematic review and meta-analysis. Reprod. Biol. Endocrinol. 2021, 19, 165. [Google Scholar] [CrossRef]
  43. Barinov, S.V.; Tirskaya, Y.I.; Shamina, I.V.; Ledovskikh, I.O.; Atamanenko, O.J. Placental blood flow and pregnancy outcomes in women with abnormal placental localization and absence of placental “migration”. J. Matern.-Fetal Neonatal Med. 2021, 34, 3496–3502. [Google Scholar] [CrossRef] [PubMed]
  44. Soyal, S.M.; Mukherjee, A.; Lee, K.Y.; Li, J.; Li, H.; DeMayo, F.J.; Lydon, J.P. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 2005, 41, 58–66. [Google Scholar] [CrossRef]
  45. Tranguch, S.; Wang, H.; Daikoku, T.; Xie, H.; Smith, D.F.; Dey, S.K. FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific. J. Clin. Investig. 2007, 117, 1824–1834. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Tranguch, S.; Cheung-Flynn, J.; Daikoku, T.; Prapapanich, V.; Cox, M.B.; Xie, H.; Wang, H.; Das, S.K.; Smith, D.F.; Dey, S.K. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. USA 2005, 102, 14326–14331. [Google Scholar] [CrossRef] [Green Version]
  47. Daikoku, T.; Tranguch, S.; Trofimova, I.N.; Dinulescu, D.M.; Jacks, T.; Nikitin, A.Y.; Connolly, D.C.; Dey, S.K. Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res. 2006, 66, 2527–2531. [Google Scholar] [CrossRef] [Green Version]
  48. Iizuka, T.; Wakae, K.; Nakamura, M.; Kitamura, K.; Ono, M.; Fujiwara, H.; Muramatsu, M. APOBEC3G is increasingly expressed on the human uterine cervical intraepithelial neoplasia along with disease progression. Am. J. Reprod. Immunol. 2017, 78, e12703. [Google Scholar] [CrossRef]
  49. Kadota, K.; Nakai, Y.; Shimizu, K. A weighted average difference method for detecting differentially expressed genes from microarray data. Algorithms Mol. Biol. 2008, 3, 8. [Google Scholar] [CrossRef] [Green Version]
Ijms 23 07637 g001 550
Figure 1. Bmal1 cKO uteri showed efficient deletion of BMAL1 and no live birth. (A–C) The uterine deletion of BMAL1 was observed by (A) RT-PCR, (B) Western blotting, and (C) immunofluorescence. (D) Uterine Bmal1 cKO mice showed no live births. The bar shows SE. ACTB, ACTIN; em, endometrium; mm/i, inner circular layer of myometrium; mm/o, the outer longitudinal layer of myometrium; ND, not determined. The scale bar shows 200 µm.
Figure 1. Bmal1 cKO uteri showed efficient deletion of BMAL1 and no live birth. (A–C) The uterine deletion of BMAL1 was observed by (A) RT-PCR, (B) Western blotting, and (C) immunofluorescence. (D) Uterine Bmal1 cKO mice showed no live births. The bar shows SE. ACTB, ACTIN; em, endometrium; mm/i, inner circular layer of myometrium; mm/o, the outer longitudinal layer of myometrium; ND, not determined. The scale bar shows 200 µm.
Ijms 23 07637 g001
Ijms 23 07637 g002 550
Figure 2. The miscarriage rate is increased in cKO mice after implantation. (A,B) Representative of uteri and HE-stained section of implantation sites from WT and cKO on days 5 (A) and 6 (B) of pregnancy. (C) Representative of uteri of WT and cKO on day 8. (D) HE-stained section of implantation sites and area of the blood vessel (BV) on day 8. (E) Although the difference is not significant, the calculated pixel areas of the blood vessel cavities in the mesometrial region in the cKO seem decreased compared to those in WT. The scale bar shows 100 µm. Arrowheads show embryo. Circles show uterine vessels in the mesometrial region. le, luminal epithelium; ge, glandular epithelium; st, endometrial stroma; mm, myometrium.
Figure 2. The miscarriage rate is increased in cKO mice after implantation. (A,B) Representative of uteri and HE-stained section of implantation sites from WT and cKO on days 5 (A) and 6 (B) of pregnancy. (C) Representative of uteri of WT and cKO on day 8. (D) HE-stained section of implantation sites and area of the blood vessel (BV) on day 8. (E) Although the difference is not significant, the calculated pixel areas of the blood vessel cavities in the mesometrial region in the cKO seem decreased compared to those in WT. The scale bar shows 100 µm. Arrowheads show embryo. Circles show uterine vessels in the mesometrial region. le, luminal epithelium; ge, glandular epithelium; st, endometrial stroma; mm, myometrium.
Ijms 23 07637 g002
Ijms 23 07637 g003a 550Ijms 23 07637 g003b 550
Figure 3. cKO mice show abnormal placental formation on day 12 of pregnancy. (A) Representative of uteri from WT and cKO on day 12 of pregnancy. (B–D) HE-stained section of the placenta. Blue-dotted areas show maternal blood vessels. Red-dotted areas show fetal blood vessels which contain nucleated erythrocytes. (E) The percentage of the maternal blood vessels that contains denucleated red blood cells (RBC). The bar shows SE. Differences in the ratio of calculated areas of maternal vessels between the wild-type and cKO mice were analyzed by the unpaired t-test. p < 0.05. The scale bar shows 100 µm.
Figure 3. cKO mice show abnormal placental formation on day 12 of pregnancy. (A) Representative of uteri from WT and cKO on day 12 of pregnancy. (B–D) HE-stained section of the placenta. Blue-dotted areas show maternal blood vessels. Red-dotted areas show fetal blood vessels which contain nucleated erythrocytes. (E) The percentage of the maternal blood vessels that contains denucleated red blood cells (RBC). The bar shows SE. Differences in the ratio of calculated areas of maternal vessels between the wild-type and cKO mice were analyzed by the unpaired t-test. p < 0.05. The scale bar shows 100 µm.
Ijms 23 07637 g003aIjms 23 07637 g003b
Ijms 23 07637 g004 550
Figure 4. The immune environment in cKO uteri. (A) Gene ontology analysis with microarray data. The top 11 groups are shown. (B) DBA/PAS double staining with the placenta on day 12 of pregnancy. Black arrowheads show PAS-positive and DBA-negative cells. White arrowheads show both PAS- and DBA-positive cells. (C) In cKO mice, numbers of DBA-positive and -negative uNK cells were significantly lower than those in WT. (D) CD161 staining with the placenta on day 12 of pregnancy. In the WT placenta, CD161 was expressed on uNK cells in both the decidua (upper panel, white arrowheads) and spongiotrophoblast layers (upper panel, arrows). In contrast, uNK cells in the decidua layer of cKO mice expressed CD161 (lower panel, white arrowheads) but its expression was hardly detected in uNK cells in the spongiotrophoblast layer (lower panel, arrows). Arrows show CD161 positive cells. The scale bar shows 100 µm.
Figure 4. The immune environment in cKO uteri. (A) Gene ontology analysis with microarray data. The top 11 groups are shown. (B) DBA/PAS double staining with the placenta on day 12 of pregnancy. Black arrowheads show PAS-positive and DBA-negative cells. White arrowheads show both PAS- and DBA-positive cells. (C) In cKO mice, numbers of DBA-positive and -negative uNK cells were significantly lower than those in WT. (D) CD161 staining with the placenta on day 12 of pregnancy. In the WT placenta, CD161 was expressed on uNK cells in both the decidua (upper panel, white arrowheads) and spongiotrophoblast layers (upper panel, arrows). In contrast, uNK cells in the decidua layer of cKO mice expressed CD161 (lower panel, white arrowheads) but its expression was hardly detected in uNK cells in the spongiotrophoblast layer (lower panel, arrows). Arrows show CD161 positive cells. The scale bar shows 100 µm.
Ijms 23 07637 g004
Ijms 23 07637 g005a 550Ijms 23 07637 g005b 550
Figure 5. P4 supplement rescues pregnancy failure in cKO mice. (A) Serum P4 levels in WT and cKO on days 8 and 12 of pregnancy. The mean P4 levels in the control group (WT, n = 5) and in the cKO groups with normal implantation (w/IS, n = 2) and with confirmed inhalation (w/o IS, n = 4) on day 8 of pregnancy, and those in the control group (WT, n = 4), the cKO groups with implantation (w/IS, n = 4) and without implantation (w/o IS, n = 6), and the progesterone-treated cKO group (w/P4, n = 5) on day 12 of pregnancy. The bar shows STDEV. Differences between groups were analyzed by the unpaired t-test. *, p < 0.01; **, p < 0.05. (B,C) Representative of the uterus of WT and cKO with P4 supplementation on days 8 (B) and 12 (C) of pregnancy. (D,E) Representative of HE-stained uterus of WT and cKO with P4 supplementation on days 8 (D) and 12 (E). (F) The percentage of maternal blood vessels, which contain denucleated red blood cells (RBC). The bar shows SE. Differences in the ratio of calculated areas of maternal vessels between the WT and cKO mice were analyzed by the unpaired t-test. (G) DBA/PAS double staining of the placenta from cKO with P4 supplementation on day 12 of pregnancy. Black arrowheads show PAS-positive and DBA-negative cells. White arrowheads show both PAS- and DBA-positive cells. (H) Numbers of DBA-positive and -negative uNK cells were not significantly different between cKO and cKO witn P4 supplementation. (I) CD161 staining of the placenta from cKO with P4 supplementation on day 12 of pregnancy. Arrows show CD161 positive cells in the spongiotrophoblast layers. The scale bar shows 100 µm. N.S., not significant.
Figure 5. P4 supplement rescues pregnancy failure in cKO mice. (A) Serum P4 levels in WT and cKO on days 8 and 12 of pregnancy. The mean P4 levels in the control group (WT, n = 5) and in the cKO groups with normal implantation (w/IS, n = 2) and with confirmed inhalation (w/o IS, n = 4) on day 8 of pregnancy, and those in the control group (WT, n = 4), the cKO groups with implantation (w/IS, n = 4) and without implantation (w/o IS, n = 6), and the progesterone-treated cKO group (w/P4, n = 5) on day 12 of pregnancy. The bar shows STDEV. Differences between groups were analyzed by the unpaired t-test. *, p < 0.01; **, p < 0.05. (B,C) Representative of the uterus of WT and cKO with P4 supplementation on days 8 (B) and 12 (C) of pregnancy. (D,E) Representative of HE-stained uterus of WT and cKO with P4 supplementation on days 8 (D) and 12 (E). (F) The percentage of maternal blood vessels, which contain denucleated red blood cells (RBC). The bar shows SE. Differences in the ratio of calculated areas of maternal vessels between the WT and cKO mice were analyzed by the unpaired t-test. (G) DBA/PAS double staining of the placenta from cKO with P4 supplementation on day 12 of pregnancy. Black arrowheads show PAS-positive and DBA-negative cells. White arrowheads show both PAS- and DBA-positive cells. (H) Numbers of DBA-positive and -negative uNK cells were not significantly different between cKO and cKO witn P4 supplementation. (I) CD161 staining of the placenta from cKO with P4 supplementation on day 12 of pregnancy. Arrows show CD161 positive cells in the spongiotrophoblast layers. The scale bar shows 100 µm. N.S., not significant.
Ijms 23 07637 g005aIjms 23 07637 g005b
Table
Table 1. cKO mice start to fail pregnancy maintenance after day six of pregnancy.
Table 1. cKO mice start to fail pregnancy maintenance after day six of pregnancy.
Day of PregnancyGenotypeNo. of MiceNo. of Mice with Normal IS (%)Mean No. of IS Sites (No. ± SE) *
Day 5WT8100.08.3 ± 0.65
cKO11100.08.3 ± 0.38
Day 6WT1485.79.4 ± 0.40
cKO2157.17.1 ± 0.67
Day 8WT1681.38.8 ± 0.53
cKO30 **40.07.3 ± 0.56
Day 12WT2085.09.5 ± 0.46
cKO3920.57.6 ± 1.00
* Mean IS numbers among only female mice with normal IS; ** 7 out of 30 mice had resorption. WT; Bmal1f/f/PR+/+, cKO; Bmal1f/f/PRcre/+, IS; implantation site.
Table
Table 2. P4 supplementation partially rescues pregnancy of cKO mice.
Table 2. P4 supplementation partially rescues pregnancy of cKO mice.
Day of PregnancyGenotypeNo. of MiceNo. of Mice with IS (%)Mean No. of IS Sites (No. ± SE)
Day 8WT + P44100.08.5 ± 0.50
cKO + P41080.08.6 ± 0.46
Day 12WT + P48100.06.5 ± 1.10
cKO + P41957.95.8 ± 0.91
WT; Bmal1f/f/PR+/+, cKO; Bmal1f/f/PRcre/+.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ono, M.; Toyoda, N.; Kagami, K.; Hosono, T.; Matsumoto, T.; Horike, S.-i.; Yamazaki, R.; Nakamura, M.; Mizumoto, Y.; Fujiwara, T.; et al. Uterine Deletion of Bmal1 Impairs Placental Vascularization and Induces Intrauterine Fetal Death in Mice. Int. J. Mol. Sci. 2022, 23, 7637. https://doi.org/10.3390/ijms23147637

AMA Style

Ono M, Toyoda N, Kagami K, Hosono T, Matsumoto T, Horike S-i, Yamazaki R, Nakamura M, Mizumoto Y, Fujiwara T, et al. Uterine Deletion of Bmal1 Impairs Placental Vascularization and Induces Intrauterine Fetal Death in Mice. International Journal of Molecular Sciences. 2022; 23(14):7637. https://doi.org/10.3390/ijms23147637

Chicago/Turabian Style

Ono, Masanori, Natsumi Toyoda, Kyosuke Kagami, Takashi Hosono, Takeo Matsumoto, Shin-ichi Horike, Rena Yamazaki, Mitsuhiro Nakamura, Yasunari Mizumoto, Tomoko Fujiwara, and et al. 2022. "Uterine Deletion of Bmal1 Impairs Placental Vascularization and Induces Intrauterine Fetal Death in Mice" International Journal of Molecular Sciences 23, no. 14: 7637. https://doi.org/10.3390/ijms23147637

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop